Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Pulmozyme to Treat Severe Asthma Episodes

This study has been completed.
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by:
North Shore Long Island Jewish Health System
ClinicalTrials.gov Identifier:
NCT00169962
First received: September 12, 2005
Last updated: December 21, 2007
Last verified: December 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2006
  Primary Completion Date: September 2006 (Final data collection date for primary outcome measure)
No publications provided by North Shore Long Island Jewish Health System

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):